DeviceSpace - Print News Article

NeuroMetrix, Inc. (NURO) to Present at Rodman & Renshaw Annual Global Investment Conference 9/8/2011 9:10:04 AM WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a science-based health care company improving patient care through neurotechnology, today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the Rodman & Renshaw Annual Global Investment Conference at The Waldorf Astoria, New York, NY on September 11-13, 2011. Dr. Gozani intends to provide an update on the Company’s business activities and on its new product NC-stat® DPNCheckTM for testing of systemic neuropathies such as diabetic peripheral neuropathy (DPN).

NeuroMetrix, Inc. (NURO) to Present at Rodman & Renshaw Annual Global Investment Conference
9/8/2011 9:10:04 AM

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a science-based health care company improving patient care through neurotechnology, today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the Rodman & Renshaw Annual Global Investment Conference at The Waldorf Astoria, New York, NY on September 11-13, 2011. Dr. Gozani intends to provide an update on the Company’s business activities and on its new product NC-stat® DPNCheckTM for testing of systemic neuropathies such as diabetic peripheral neuropathy (DPN).